CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 30 filers reported holding CLOVIS ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $9,264,000 | -13.9% | 8,000,000 | 0.0% | 0.00% | -20.0% |
| Q4 2017 | $10,765,000 | -12.7% | 8,000,000 | 0.0% | 0.01% | -16.7% |
| Q3 2017 | $12,330,000 | -10.1% | 8,000,000 | -1.2% | 0.01% | -14.3% |
| Q2 2017 | $13,710,000 | +294.4% | 8,100,000 | +200.0% | 0.01% | +250.0% |
| Q1 2017 | $3,476,000 | -3.3% | 2,700,000 | -22.9% | 0.00% | 0.0% |
| Q4 2016 | $3,596,000 | -58.2% | 3,500,000 | -61.5% | 0.00% | -60.0% |
| Q3 2016 | $8,600,000 | +196.8% | 9,100,000 | +122.0% | 0.01% | +150.0% |
| Q2 2016 | $2,898,000 | +37.9% | 4,100,000 | +32.3% | 0.00% | +100.0% |
| Q1 2016 | $2,102,000 | -31.1% | 3,100,000 | -13.2% | 0.00% | -50.0% |
| Q4 2015 | $3,052,000 | -64.1% | 3,570,000 | -29.9% | 0.00% | -60.0% |
| Q3 2015 | $8,497,000 | – | 5,090,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 43,295,000 | $29,665,000 | 1.82% |
| Telemetry Investments, L.L.C. | 7,000,000 | $4,747,000 | 1.38% |
| Baker Brothers Advisors | 129,300,000 | $87,801,000 | 0.93% |
| Castle Creek Arbitrage, LLC | 5,500,000 | $3,755,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 14,300,000 | $9,730,000 | 0.28% |
| Verition Fund Management LLC | 1,966,000 | $1,343,000 | 0.22% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 11,625,000 | $7,960,000,000 | 0.15% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $4,106,000 | 0.12% |
| PFM Health Sciences, LP | 4,747,000 | $3,243,000 | 0.10% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 11,500 | $3,568,000 | 0.04% |